May 1, 2026

Uncategorized

Tirzepatide safe, effective for weight loss, preventing diabetes progression at 3 years

Team Metabolic Health Tirzepatide demonstrated long-term weight-loss benefits and prevention of diabetes progression in patients with obesity and prediabetes, but…

Zealand Pharma to start Phase 2b trial for obesity drug candidate in Q4

Team Metabolic Health Danish biotechnology company Zealand Pharma (ZELA.CO), said on Thursday it expected to initiate a so-called Phase 2b…

Eli Lilly gets nod to launch weight-loss drug in Hong Kong – Bloomberg News

Team Metabolic Health A box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes made by Lilly…

80% of Strokes Are Preventable and GLP-1 drugs are beneficial for cardiovascular health

Finding to be extremely effective in treating risk factors for stroke, American Stroke Association incorporates the important new class of…

Can weight loss drug semaglutide slow down ageing? Here’s looking at its multiple benefits

Team Metabolic Health Given their effects on various organs, they could potentially help you remain functional “New diabetes drugs may…

The Novo Nordisk scientist behind Ozempic, Wegovy weight loss research

Team Metabolic Health Credit: You Tube Channel 60 Minutes

AstraZeneca says experimental obesity pill safe in early-stage trial

Team Metabolic Health AstraZeneca (AZN.L), opens new tab said on Monday its experimental weight-loss pill, licensed a year ago from…

Novo Nordisk expects high demand for its obesity drugs in India, says country head

Team Metabolic Health Popular weight-loss drug Wegovy maker Novo Nordisk (NOVOb.CO) expects high demand and acceptance for its anti-obesity drug,…

Novo Nordisk affirms 25% weight-loss expectation for experimental drug CagriSema

Team Metabolic Health Novo Nordisk (NOVOb.CO), opens new tab said the side effects in trials so far for its experimental…

Novo Nordisk lifts curbs on Wegovy prescriptions in the U.S., says CEO

Team Metabolic Health Novo Nordisk (NOVOb.CO), opens new tab is lifting curbs on prescriptions of its weight-loss drug Wegovy in…

Weight loss drug semaglutide may offer relief for knee arthritis pain

Team Metabolic Health New research highlights the potential for weight-loss medication to ease arthritis symptoms, offering hope for improved mobility…

Semaglutide may reduce Alzheimer’s risk in diabetics

Team Metabolic Health Semaglutide linked to 40-70% lower risk of first-time Alzheimer’s diagnosis in type 2 diabetes patients compared to other antidiabetic…

Weight-Loss Meds Like Wegovy Could Battle Alcoholism

Team Metabolic Health Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid…

How will weight-loss drugs change our relationship with food?

Team Metabolic Health Decisions on how these drugs will be used look likely to shape our future health and even…

Eli Lilly vs. Novo Nordisk: Which Weight Loss Stock is The Better Opportunity Over The Next 10 Years?

Team Metabolic Health Glucagon-like peptide-1 (GLP-1) agonists have taken the healthcare world by storm, emerging as mainstream treatments for patients…